Search:
SHARE PRINT

Fact sheets about GAVI

All documents are in Adobe Acrobat PDF format unless otherwise noted.

The GAVI Alliance

A brief description of the GAVI Alliance and Fund
(updated July 2010)


Financing country demand for life-saving vaccines

In addition to current and expected donor
commitments, GAVI requires a further US$ 2.6 billion over six years to allow the introduction of pneumococcal and rotavirus vaccines, the complete roll out of pentavalent vaccine and the advancement of new vaccines: HPV, Japanese encephalitis, meningitis, rubella and typhoid.
(updated August 2010)


2000-2010
A Decade of Saving Lives

The impressive results of GAVI’s first 10 years demonstrate the power of immunisation.
(updated February 2010)


GAVI's Accelerated Vaccine Introduction Initiative (AVI)

GAVI launched the AVI initiative in January 2009 to facilitate the rapid and large-scale introduction of pneumococcal and rotavirus vaccines in GAVI-eligible countries and to establish a platform for future introduction of other new vaccines.
(updated December 2009)

Health system strengthening

Learn about GAVI's involvement in health system strengthening
(updated December 2009)

Questions and answers about health system strengthening

Learn more about GAVI's involvement in health system strengthening
(updated February 2008)

GAVI collaboration with Civil Society Organisations (CSOs)

Learn how GAVI supports civil society organisations (CSOs) to deliver immunisation services and influence decision-makers
(updated March 2010)

    Advance Market Commitment (AMC)

    Learn about Advance Market Commitment, including the pilot AMC for pneumococcal vaccines
    (updated November 2009)

    Questions and answers about the Advance Market Commitment (AMC)

    FAQs about the Advance Market Commitment and the pilot AMC for pneumococcal vaccines.
    (updated January 2010)

    Supporters of the Advance Market Commitment (AMC)

    Find out who are the supporters of Advance Market Commitment for vaccines
    (updated October 2007)

    The Pneumococcal Advance Market Commitment (AMC): the Process

    Learn more about the Advance Market Commitment process
    (updated November 2009)

    Advance Market Commitment to Developing Countries

    Speeding up access to new and affordable vaccines for developing countries.
    (updated November 2009)

    New vaccines
    co-financing Q&A

    Learn how countries share the cost of vaccines supplied by GAVI to ensure immunisation programmes are sustainable
    (updated July 2008)

    Human Papillomavirus (HPV)

    The GAVI Alliance prioritised support for HPV vaccines as part of its new vaccine investment strategy.
    (updated May 2010)

    GAVI in Vietnam

    With the support of the GAVI Alliance, Vietnam is making considerable improvements in the health of its population and providing valuable, life-saving protection for future generations.
    (updated November 2009)